Restricted accessResearch articleFirst published online 2010-06
Genistein Does Not Affect Vascularization and Blood Perfusion of Endometriotic Lesions and Ovarian Follicles in Dorsal Skinfold Chambers of Syrian Golden Hamsters
Genistein has previously been shown to cause regression of endometriotic lesions. In the current study, we investigated whether this observation is due to the antiangiogenic activity of genistein. Endometrial fragments and ovarian follicles were transplanted into dorsal skinfold chambers of hamsters, which were treated with genistein (50 and 200 mg/kg) or vehicle (control). Vascularization and blood perfusion of the grafts was analyzed over 14 days using intravital fluorescence microscopy and histology. Genistein inhibited angiogenesis neither in endometriotic lesions nor in ovarian follicles. This was indicated by a final microvessel density of the grafts, which was comparable to that of controls. Blood perfusion was not affected by genistein treatment. At day 14 after transplantation, the grafts of genistein- and vehicle-treated animals exhibited a histomorphology, which was typical for well-vascularized endometriotic lesions and ovarian follicles without any signs of regression. Thus, genistein may not be considered for the development of antiangiogenic treatment strategies in the therapy of endometriosis.
Galle PCClinical presentation and diagnosis of endometriosis. Obstet Gynecol Clin North Am. 1989;16(1):29-42.
2.
Sampson JAPeritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol. 1927;14:422-469.
3.
Groothuis PG , Nap AW, Winterhager E., Grümmer R.Vascular development in endometriosis. Angiogenesis. 2005; 8(2):147-156.
4.
Nothnick WB, D’Hooghe TMMedical management of endometriosis: novel targets and approaches towards the development of future treatment regimes. Gynecol Obstet Invest. 2003;55(4):189-198.
Caserta D., Maranghi L., Mantovani A., Marci R., Maranghi F., Moscarini M.Impact of endocrine disruptor chemicals in gynaecology. Hum Reprod Update. 2008;14(1):59-72.
7.
Cotroneo MS, Lamartiniere CAPharmacologic, but not dietary, genistein supports endometriosis in a rat model. Toxicol Sci. 2001;61(1):68-75.
8.
Yavuz E., Oktem M., Esinler I., Toru SA, Zeyneloglu HBGenistein causes regression of endometriotic implants in the rat model. Fertil Steril. 2007;88(4 suppl):1129-1134.
9.
Piao M., Mori D., Satoh T., Sugita Y., Tokunaga O.Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Endothelium. 2006 ;13(4):249-266.
10.
Guo Y., Wang S., Hoot DR, Clinton SKSuppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J Nutr Biochem. 2007;18(6):408-417.
11.
Büchler P., Reber HA, Büchler MW, Friess H., Lavey RS, Hines OJAntiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer. 2004;100(1):201-210.
12.
Gu Y., Zhu CF, Iwamoto H., Chen JSGenistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol. 2005;11(41):6512-6517.
13.
Farina HG, Pomies M., Alonso DF, Gomez DEAntitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep. 2006;16(4):885-891.
14.
May K., Becker CMEndometriosis and angiogenesis. Minerva Ginecol. 2008;60(3):245-254.
15.
Laschke MW, Elitzsch A., Vollmar B., Menger MDIn vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy. Fertil Steril. 2005 ;84(suppl 2): 1199-1209.
16.
Laschke MW, Elitzsch A., Scheuer C., Holstein JH, Vollmar B., Menger MDRapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol. 2006 ;149(2):137-144.
17.
Laschke MW, Elitzsch A., Scheuer C., Vollmar B., Menger MDSelective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril . 2007;87(1):163-171.
18.
Vollmar B., Laschke MW, Rohan R., Koenig J., Menger MDIn vivo imaging of physiological angiogenesis from immature to preovulatory ovarian follicles. Am J Pathol. 2001;159(5): 1661-1670.
19.
Gross GHA technique for sustained synchronization of hamster estrous cycles by hormonal means. Horm Behav. 1977;9(1):23-31.
20.
Laschke MW, Menger MDIn vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update. 2007;13(4):331-342.
21.
Laschke MW, Schwender C., Scheuer C., Vollmar B., Menger MDDietary glycine does not affect physiological angiogenesis and reproductive function, but inhibits apoptosis in endometrial and ovarian tissue by down-regulation of nuclear factor-kappaB. Fertil Steril. 2008 ;90(4 suppl): 1460-1469.
22.
Laschke MW, Schwender C., Scheuer C., Vollmar B., Menger MDEpigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod. 2008;23(10):2308-2318.
23.
Menger MD, Laschke MW, Vollmar B.Viewing the micro-circulation through the window: some twenty years experience with the hamster dorsal skinfold chamber. Eur Surg Res. 2002;34(1-2):83-91.
24.
Baker M., Wayland H.On-line volume flow rate and velocity profile measurement for blood in microvessels . Microvasc Res. 1974;7(1):131-143.
25.
Becker CM, Rohwer N., Funakoshi T., et al. 2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol. 2008;172(2):534-544.
26.
Di Blasio AM , Centinaio G., Carniti C., Somigliana E., Viganò P., Vignali M.Basic fibroblast growth factor messenger ribonucleic acid levels in eutopic and ectopic human endometrial stromal cells as assessed by competitive polymerase chain reaction amplification. Mol Cell Endocrinol. 1995;115(2): 169-175.
27.
Surrey ES, Halme J.Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro: a model for endometriosis? Fertil Steril. 1991;56(4):672-679.
28.
Piva M., Horowitz GM, Sharpe-Timms KLInterleukin-6 differentially stimulates haptoglobin production by peritoneal and endometriotic cells in vitro: a model for endometrial-peritoneal interaction in endometriosis. J Clin Endocrinol Metab. 2001;86(6):2553-2561.
29.
Ria R., Loverro G., Vacca A., et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. Eur J Clin Invest. 2002;32(3):199-206.
30.
Absenger Y. , Hess-Stumpp H., Kreft B., et al. Cyr61, a deregulated gene in endometriosis . Mol Hum Reprod. 2004;10(6): 399-407.
31.
Laschke MW, Elitzsch A., Vollmar B., Vajkoczy P., Menger MDCombined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod. 2006;21(1):262-268.
32.
Nap AW, Groothuis PG, Demir AY, et al. Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod . 2003; 18(1):30-34.
33.
Laschke MW, Vollmar B., Menger MDInosculation: connecting the life-sustaining pipelines. Tissue Eng Part B Rev.2009;15(4):455-465.
34.
Mathieson RA , Kitts WDBinding of phyto-oestrogen and oestradiol-17 beta by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol. 1980;85(2): 317-325.
35.
Kuiper GG, Lemmen JG, Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998 ;139(10):4252-4263.
36.
Folman Y., Pope GSThe interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol. 1966;34(2):215-225.
37.
Foth D., Cline JMEffects of mammalian and plant estrogens on mammary glands and uteri of macaques . Am J Clin Nutr. 1998;68(6 suppl):1413S-1417S.
38.
Jefferson WN , Padilla-Banks E., Newbold RRDisruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol. 2007;23(3):308-316.
